From early discovery screening to formulation profiling, the ORYL F1 delivers decision-ready solubility and aggregation results across a wide range of applications — explore to see how the ORYL F1 can support your workflow.
Fully validated, customer-anchored use-cases where the ORYL F1 is already delivering value in pharma R&D pipelines — see Application Notes for details.
Applications within the ORYL F1’s capabilities that we are actively developing — reach out if you see a fit, we’re always open to new partnerships.
Screen surfactants, sugars, amino acids, salts, and buffers for small molecule and biologic stabilization at plate scale — matrix sizes traditional methods choke on.
Aggregation propensity, viscosity proxies, and formulation ranking at concentrations where DLS saturates and B22 measurement is too slow to scale.
Track precipitation kinetics from supersaturated states with fine temporal resolution. Lag phase, nucleation, growth — captured directly.
Detect label-free protein-protein / protein-peptide assembly events (binding, conformational ordering, ternary PROTAC complexes) via SHS+LLS signatures.
Rank conditions for antigen-on-adjuvant adsorption efficiency, reading the adsorbed protein directly rather than inferring from supernatant depletion.
Screen crystallization conditions by monitoring nucleation and crystal-form emergence directly via SHS. No transparency requirement on the matrix.
Detailed application data and workflows are available in our resource library.
Discuss your workflow with ORYL and see how the ORYL F1 can support your research.
